Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Alexander Menter"'
Autor:
Scott A. Tomlins, Nickolay A. Khazanov, Benjamin J. Bulen, Daniel H. Hovelson, Melissa J. Shreve, Laura E. Lamb, Marc R. Matrana, Mark E. Burkard, Eddy Shih-Hsin Yang, William Jeffery Edenfield, E. Claire Dees, Adedayo A. Onitilo, Michael Thompson, Gary L. Buchschacher, Alan M. Miller, Alexander Menter, Benjamin Parsons, Timothy Wassenaar, Leon C. Hwang, J. Marie Suga, Robert Siegel, William Irvin, Suresh Nair, Jennifer N. Slim, Jamal Misleh, Jamil Khatri, Gregory Masters, Sachdev Thomas, Malek Safa, Daniel M. Anderson, Kat Kwiatkowski, Khalis Mitchell, Tina Hu-Seliger, Stephanie Drewery, Andrew Fischer, Komal Plouffe, Eric Czuprenski, Jennifer Hipp, Travis Reeder, Hana Vakil, D. Bryan Johnson, Daniel R. Rhodes
Publikováno v:
Communications Medicine, Vol 3, Iss 1, Pp 1-14 (2023)
Tomlins et al. develop an Immunotherapy Response Score (IRS) to predict clinical benefit from checkpoint inhibition across solid tumors. IRS integrates TMB and gene expression, is evaluable from FFPE material, and is predictive for real-world progres
Externí odkaz:
https://doaj.org/article/4592ab4c5780454fabd8956daa3f8f79
Autor:
Juraj Kavecansky, Richie Xu, Lue-Yen Tucker, Jahan Tavakoli, Alexander Menter, Thach-Giao Truong
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Nickolay Khazanov, Melissa Shreve, Laura Lamb, Daniel Hovelson, Marc Matrana, Mark Burkard, Eddy Yang, William Edenfield, Claire Dees, Adedayo Onitilo, Michael Thompson, Gary Buchschacher, Alan Miller, Alexander Menter, Benjamin Parsons, Timothy Wassenaar, Leon Hwang, J. Suga, Robert Siegel, William Irvin, Suresh Nair, Jennifer Slim, Kat Kwiatkowski, Khalis Mitchell, Tina Hu-Seliger, Stephanie Drewery, Andrew Fischer, Jennifer Hipp, Travis Reeder, Hana Vakil, Bryan Johnson, Daniel Rhodes, Scott Tomlins
Pembrolizumab is approved in many advanced solid tumor types, however predictive biomarkers and the proportion of pembrolizumab-benefiting patients vary. Biomarkers beyond PD-L1 immunohistochemistry, microsatellite instability (MSI) status, and tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d44f832c2a2425bf32a36e8fa251391
https://doi.org/10.21203/rs.3.rs-1225960/v1
https://doi.org/10.21203/rs.3.rs-1225960/v1
Autor:
Karen Kelly, Martha Persky, Samir E. Witta, Alexander Menter, Amy Gibbs, A. Scott Pierson, Scott N. Holden, Patrick Pallansch, Paul A. Bunn, S. Gail Eckhardt, Daniel C. Chan, Chan Zeng, Michael E. Long, Anna E. Barón, Daniel L. Gustafson, Cindy L. O'Bryant, Michele Basche
Publikováno v:
Clinical Cancer Research. 10:7229-7237
Purpose: Exisulind (sulindac sulfone, FGN-1, Aptosyn) is a sulindac metabolite that induces apoptosis via inhibition of cyclic GMP-phosphodiesterase. This agent demonstrated tumor growth inhibition in rodent models of colon, breast, prostate, and lun
Autor:
Alexander, Menter, Alexander, Urquhart, Virginia, Borges, Rachel, Rabinovitch, Meenakshi, Singh, William, Robinson, Paul, Seligman, Christina, Finlayson, Anthony, Elias
Publikováno v:
Oncology (Williston Park, N.Y.). 20(9)
Publikováno v:
Integrative cancer therapies. 4(2)
In recent studies, patients have reported an increased use of complementary and alternative medicine (CAM). Acupuncture is a popular complementary therapy for patients with cancer. This article will provide current cancer treatment providers with inf